Statistics for Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation
Total visits
| views | |
|---|---|
| Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation | 72 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| Hamadani2008Addition-CCBYNCND.pdf | 19 |
Top country views
| views | |
|---|---|
| United States | 66 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 43 |
| Fairfield | 5 |
| Houston | 5 |
| Ann Arbor | 3 |
| White Plains | 3 |
| Cambridge | 1 |
| Indianapolis | 1 |
| Mount Laurel | 1 |
| Seremban | 1 |